Literature DB >> 35537780

Myeloid CCR2 Promotes Atherosclerosis after AKI.

Anne M Hüsing1, Vera C Wulfmeyer1, Svenja Gaedcke2, Susanne V Fleig1,3, Song Rong1, David DeLuca2, Hermann Haller1, Roland Schmitt1, Sibylle von Vietinghoff4,3.   

Abstract

BACKGROUND: The risk of cardiovascular events rises after AKI. Leukocytes promote atherosclerotic plaque growth and instability. We established a model of enhanced remote atherosclerosis after renal ischemia-reperfusion (IR) injury and investigated the underlying inflammatory mechanisms.
METHODS: Atherosclerotic lesions and inflammation were investigated in native and bone marrow-transplanted LDL receptor-deficient (LDLr-/- ) mice after unilateral renal IR injury using histology, flow cytometry, and gene expression analysis.
RESULTS: Aortic root atherosclerotic lesions were significantly larger after renal IR injury than in controls. A gene expression screen revealed enrichment for chemokines and their cognate receptors in aortas of IR-injured mice in early atherosclerosis, and of T cell-associated genes in advanced disease. Confocal microscopy revealed increased aortic macrophage proximity to T cells. Differential aortic inflammatory gene regulation in IR-injured mice largely paralleled the pattern in the injured kidney. Single-cell analysis identified renal cell types that produced soluble mediators upregulated in the atherosclerotic aorta. The analysis revealed a marked early increase in Ccl2, which CCR2+ myeloid cells mainly expressed. CCR2 mediated myeloid cell homing to the post-ischemic kidney in a cell-individual manner. Reconstitution with Ccr2-/- bone marrow dampened renal post-ischemic inflammation, reduced aortic Ccl2 and inflammatory macrophage marker CD11c, and abrogated excess aortic atherosclerotic plaque formation after renal IR.
CONCLUSIONS: Our data introduce an experimental model of remote proatherogenic effects of renal IR and delineate myeloid CCR2 signaling as a mechanistic requirement. Monocytes should be considered as mobile mediators when addressing systemic vascular sequelae of kidney injury.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  acute kidney injury; arteriosclerosis; cardiovascular disease; chronic inflammation; macrophages; renal ischemia

Year:  2022        PMID: 35537780      PMCID: PMC9342642          DOI: 10.1681/ASN.2022010048

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  43 in total

Review 1.  Uremic lung: new insights into a forgotten condition.

Authors:  Paul J Scheel; Manchang Liu; Hamid Rabb
Journal:  Kidney Int       Date:  2008-10       Impact factor: 10.612

Review 2.  Monocyte recruitment during infection and inflammation.

Authors:  Chao Shi; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2011-10-10       Impact factor: 53.106

3.  Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.

Authors:  L Parker Gregg; Maria Clarissa Tio; Xilong Li; Beverley Adams-Huet; James A de Lemos; S Susan Hedayati
Journal:  Am J Nephrol       Date:  2018-06-06       Impact factor: 3.754

4.  Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.

Authors:  T Imai; D Chantry; C J Raport; C L Wood; M Nishimura; R Godiska; O Yoshie; P W Gray
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

5.  Acute kidney injury leads to inflammation and functional changes in the brain.

Authors:  Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

6.  Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.

Authors:  Geetika Bajpai; Andrea Bredemeyer; Wenjun Li; Konstantin Zaitsev; Andrew L Koenig; Inessa Lokshina; Jayaram Mohan; Brooke Ivey; His-Min Hsiao; Carla Weinheimer; Attila Kovacs; Slava Epelman; Maxim Artyomov; Daniel Kreisel; Kory J Lavine
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 23.213

7.  Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion.

Authors:  Jing Liu; Sanjeev Kumar; Egor Dolzhenko; Gregory F Alvarado; Jinjin Guo; Can Lu; Yibu Chen; Meng Li; Mark C Dessing; Riana K Parvez; Pietro E Cippà; A Michaela Krautzberger; Gohar Saribekyan; Andrew D Smith; Andrew P McMahon
Journal:  JCI Insight       Date:  2017-09-21

8.  A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.

Authors:  Ilze Bot; Natalia V Ortiz Zacarías; Wilhelmus E A de Witte; Henk de Vries; Peter J van Santbrink; Daniël van der Velden; Mara J Kröner; Dirk-Jan van der Berg; Dean Stamos; Elizabeth C M de Lange; Johan Kuiper; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

9.  Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A.

Authors:  Johannes Nordlohne; Alexandra Helmke; Shuwang Ge; Song Rong; Rongjun Chen; Ari Waisman; Hermann Haller; Sibylle von Vietinghoff
Journal:  JACC Basic Transl Sci       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.